Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IV EV71 Inactivated Vaccine (Human Diploid Cell) Batch Consistency and Safety in 6–35-Month-Old Children
CTR20233764Phase 4Active
- Sponsor
- Institute of Medical Biology Chinese Academy of Medical Sciences
- Start
- Nov 2023
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of enterovirus type 71 vaccine, inactivated (human diploid cell) (3 arms), sponsored by Institute of Medical Biology Chinese Academy of Medical Sciences. Primary endpoint: Anti-EV71 neutralizing antibody geometric mean titer (GMT). Started Nov 2023; status: active.
02
Drugs
enterovirus type 71 vaccine, inactivated (human diploid cell)
Beyond the preview
Go deeper on CTR20233764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20233764.